Edition:
India

Bioxcel Therapeutics Expands Immuno-Oncology Partnership With Nektar


Monday, 24 Sep 2018 

Sept 24 (Reuters) - BioXcel Therapeutics Inc ::BIOXCEL THERAPEUTICS EXPANDS IMMUNO-ONCOLOGY PARTNERSHIP WITH NEKTAR INTO CLINICAL DEVELOPMENT IN PANCREATIC CANCER.BIOXCEL THERAPEUTICS INC - CO AND NEKTAR ARE EXPANDING THEIR ONGOING RESEARCH COLLABORATION INTO A NEW CLINICAL PARTNERSHIP.BIOXCEL THERAPEUTICS INC - UNDER TERMS OF AGREEMENT, CO WILL BE RESPONSIBLE FOR INITIATING AND MANAGING CLINICAL PROGRAM. 

Company Quote

6.23
-0.03 -0.48%
16 Oct 2019